These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2472470)

  • 1. Immunologic determinants of head and neck cancer response to induction chemotherapy.
    Schantz SP; Savage HE; Racz T; Liu FJ; Brown BW; Rossen RD; Hong WK
    J Clin Oncol; 1989 Jul; 7(7):857-64. PubMed ID: 2472470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
    Recondo G; Armand JP; Tellez-Bernal E; Domenge C; Belehradek M; De Vathaire F; Wibault P; Richard JM; Cvitkovic E
    Laryngoscope; 1991 May; 101(5):494-501. PubMed ID: 1709437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alteration of immunological parameters following CDDP-5-FU chemotherapy].
    Tsukuda M; Kubota A; Yosida T; Miyata K; Sawaki S
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3163-6. PubMed ID: 3190253
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer.
    Cognetti F; Pinnarö P; Ruggeri EM; Carlini P; Perrino A; Impiombato FA; Calabresi F; Chilelli MG; Giannarelli D
    J Clin Oncol; 1989 Jul; 7(7):829-37. PubMed ID: 2472469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin and 5-fluorouracil as neoadjuvant chemotherapy: predicting response in head and neck squamous cell cancer.
    Wang HM; Wang CH; Chen JS; Chang HK; Kiu MC; Liaw CC; Ng KT; Lai GM
    J Formos Med Assoc; 1995 Mar; 94(3):87-94. PubMed ID: 7613250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil.
    Amrein PC; Weitzman SA
    J Clin Oncol; 1985 Dec; 3(12):1632-9. PubMed ID: 2415693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes and chemotherapy response in patients with head and neck cancer.
    Blazar BA; Fried MP; Strome M; Clark JR; Sereno P; Rodliff S; Caminear D
    Head Neck; 1989; 11(5):431-6. PubMed ID: 2807883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of head and neck cancer].
    Kohno N; Nakazawa E; Kusunoki M; Nishiya M
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):277-82. PubMed ID: 8712819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
    J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck.
    Haddad R; Tishler R; Wirth L; Norris CM; Goguen L; Sullivan C; O'Donnell L; Li Y; Posner M
    Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):678-81. PubMed ID: 16785415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
    Panasci L; Gravenor D; Black M; Frenkiel S; Margolese R
    Cancer Treat Rep; 1985 Sep; 69(9):1015-7. PubMed ID: 2411401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
    Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.
    Colevas AD; Busse PM; Norris CM; Fried M; Tishler RB; Poulin M; Fabian RL; Fitzgerald TJ; Dreyfuss A; Peters ES; Adak S; Costello R; Barton JJ; Posner MR
    J Clin Oncol; 1998 Apr; 16(4):1331-9. PubMed ID: 9552034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
    Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results.
    Clark JR; Busse PM; Norris CM; Andersen JW; Dreyfuss AI; Rossi RM; Poulin MD; Colevas AD; Tishler RB; Costello R; Lucarini JW; Lucarini D; Thornhill L; Lackey M; Peters E; Posner MR
    J Clin Oncol; 1997 Sep; 15(9):3100-10. PubMed ID: 9294473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of levels of circulating C1q binding macromolecules with induction chemotherapy response in head and neck cancer patients.
    Schantz SP; Savage HE; Brown BW; Reuben JM; Hong WK; Rossen RD
    Cancer Res; 1988 Oct; 48(20):5868-73. PubMed ID: 3262415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary evaluation of the effectiveness of induction chemotherapy with cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the head and neck].
    Migdał K; Korzeniowski S; Skołyszewski J
    Otolaryngol Pol; 1991; 45(2):85-9. PubMed ID: 2067863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin and 5-FU infusions in therapy of advanced squamous cell carcinoma of head and neck in 50 Indian patients.
    Sharma SC; Sharma AK; Singhal KC
    Zhongguo Yao Li Xue Bao; 1990 May; 11(3):288. PubMed ID: 2088008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.